应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
RUBY Rubius Therapeutics, Inc.
已收盘 04-19 16:00:00 EDT 延时
资讯
新帖
简况
葛兰素史克(GSK.US)公布RUBY临床3期试验第1部分预定分析结果
智通财经 · 2023-10-31
葛兰素史克(GSK.US)公布RUBY临床3期试验第1部分预定分析结果
加载更多
公司概况
公司名称:
Rubius Therapeutics, Inc.
所属市场:
EXPERT
上市日期:
--
主营业务:
Rubius Therapeutics, Inc.于2013年根据特拉华州法律注册成立。该公司正在率先开发新一类药物Red Cell Therapeutics或RCT。基于他们认为人类红细胞是医学下一个重大创新的基础,他们设计了一个专有平台,用于基因工程和培养选择性,有效和即用型细胞疗法的随机对照试验。
发行价格:
--
{"stockData":{"symbol":"RUBY","market":"US","secType":"STK","nameCN":"Rubius Therapeutics, Inc.","latestPrice":0.057,"timestamp":1713556800000,"preClose":0.057,"halted":0,"volume":0,"delay":15,"floatShares":85465626,"shares":90397732,"eps":-1.989536,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"04-19 16:00:00 EDT 延时","open":0.057,"high":0.057,"low":0.057,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.989536,"exchange":"EXPERT","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1713772800000},"adr":0,"adjPreClose":0.057,"volumeRatio":0},"requestUrl":"/m/hq/s/RUBY","defaultTab":"news","newsList":[{"id":"2379566315","title":"葛兰素史克(GSK.US)公布RUBY临床3期试验第1部分预定分析结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2379566315","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2379566315?lang=zh_cn&edition=full","pubTime":"2023-10-31 09:58","pubTimestamp":1698717492,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,10月30日,葛兰素史克公布RUBY临床3期试验第1部分预定分析的结果,该试验检视了PD-1抑制剂Jemperli与卡铂和紫杉醇联合用药,并接续Jemperli作为单药,与安慰剂加化疗后安慰剂相比,在原发性晚期或复发性子宫内膜癌成人患者中的疗效与安全性。子宫内膜癌是最常见的妇科癌症之一。在子宫内膜癌治疗方面,Jemperli已获美国FDA批准,作为在先前接受过含铂疗法后的dMMR晚期或复发性子宫内膜癌的单药治疗。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1017709.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rubiustx.com","description":"Rubius Therapeutics, Inc.于2013年根据特拉华州法律注册成立。该公司正在率先开发新一类药物Red Cell Therapeutics或RCT。基于他们认为人类红细胞是医学下一个重大创新的基础,他们设计了一个专有平台,用于基因工程和培养选择性,有效和即用型细胞疗法的随机对照试验。","exchange":"EXPERT","name":"Rubius Therapeutics, Inc.","nameEN":"Rubius Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rubius Therapeutics, Inc.(RUBY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rubius Therapeutics, Inc.(RUBY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rubius Therapeutics, Inc.,RUBY,Rubius Therapeutics, Inc.股票,Rubius Therapeutics, Inc.股票老虎,Rubius Therapeutics, Inc.股票老虎国际,Rubius Therapeutics, Inc.行情,Rubius Therapeutics, Inc.股票行情,Rubius Therapeutics, Inc.股价,Rubius Therapeutics, Inc.股市,Rubius Therapeutics, Inc.股票价格,Rubius Therapeutics, Inc.股票交易,Rubius Therapeutics, Inc.股票购买,Rubius Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rubius Therapeutics, Inc.(RUBY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rubius Therapeutics, Inc.(RUBY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}